OUTSOURCING
M Lab™ Collaboration Centers Video
M Lab™ Collaboration Centers is a network comprised of scientific experts, innovative technologies, and flexible non-GMP facilities where you can troubleshoot your process, identify efficiencies, and adopt innovative techniques.
Building Resilience In Biomanufacturing Operations
In this segment from the Bioprocess Online Live event, “Protecting Bioprocessing Operations and Supply Chains In A Turbulent Economy,” panelists share their thoughts on what it means to be resilient and how organizations can embody resilience in their biomanuf...
Protecting Biopharma Manufacturing Supply Chains
In this final segment from the Bioprocess Online Live event, “Protecting Bioprocessing Operations and Supply Chains In A Turbulent Economy,” panelists Adam Golin, Jon Lindbloom, and James Sapirstein share their advice and best practices for sourcing suppliers ...
Raman PAT Platform – Model Building Support Animation
Interested in implementing Raman as a PAT tool to monitor your bioprocesses in-line and in real time? But not a chemometric expert? Our experts are here to support you! Watch this video to learn more.
How Will U.S. Tariffs And The BIOSECURE Act Impact Global Biopharma Markets?
In this segment from the Bioprocess Online Live event, “Protecting Bioprocessing Operations and Supply Chains In A Turbulent Economy,” panelists explain how tariffs imposed by the U.S. are putting competitive pressure on companies to reduce COGs. They also dis...
Discovering A Unique Multimillion Euro Nanotechnology Facility
Dr. David Rowe, Head of Manufacturing at Nanoform, provides an overview of Nanoform's manufacturing capabilities and introduces a new, state-of-the-art nanotechnology facility.
Regulatory And Biosafety Testing Expertise
Advancing biologics requires confidence in safety, quality, and compliance. Learn how integrated analytical and biosafety testing, backed by decades of expertise, helps reduce risk.
What Researchers Should Look For When Choosing A CLD Partner
A strong track record in compliant saline production and scalable quality is key when selecting a biomanufacturing partner. See how these factors help ensure regulatory alignment and long-term success.
Combining Expertise With Best-In-Class Technology
Members of the MilliporeSigma leadership team reflect on the longstanding experience of our BioReliance® viral vector manufacturing facilities. Our legacy experience, alongside our brand new facility and latest industry innovations, ensure we are a preferred partner t...
Release Your Gene Therapy With Confidence
You are developing a cell or gene therapy and now you need to deliver it quickly to patients. But first you must make sure it's safe and effective. That's where we come in. Our experts can draw a testing strategy for your specific product, process, and goals.
...
Collaboration & Expertise, The Keys To Efficiency And Scalability Across All Modalities
View this video and discover our global vaccine capabilities from process development to full-scale GMP-manufacturing and in all modalities.
Factors Which Impact mAb Process Scale-Up
Thinking about your mAb scale-up processes early on can help avoid common pitfalls. Cytiva’s Fast Trak scientists discuss factors that can influence a successful scale-up outcome.
How MilliporeSigma Promotes Quality And Risk Reduction
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.
Level Up With Product Characterization
In the race to bring a new biotherapeutic to market, unexpected obstacles can slow you down or even knock you back a few steps. But with the right information at the right time, and an experienced partner to provide scientific, regulatory, and bioprocessing guidance and s...
The Journey To Safety Through Viral Clearance
Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.
MilliporeSigma Capacity Update October 2025: ADC
MilliporeSigma and Simtra's streamlined collaboration encompasses every stage, including bioconjugation, linker and payload supplies, formulation development, and final fill/finish of drug substance.
Increasing The Reach Of Cell And Gene Therapies
The cell and gene therapy industry is rapidly evolving from the perspective of “can we commercialize this class of therapeutics?” to “how do we reach patients who need these therapies?”. However, the promise of these biologics can only be realized ...
Thermo Fisher Scientific Customer Testimonial - Libbs
An overview of Libbs product portfolio and how they benefit from Thermo Fisher Scientific services.
Microbiology Testing Systems Maintenance & Repair Services Plans
Watch to learn about microbiology testing systems maintenance and repair services plans from a company with proven expertise.
Thermo Fisher Scientific China Single-Use Technologies Capacity Expansion
Thermo Fisher Scientific is expanding our single-use manufacturing network globally. With continuous growth in China’s population, we have seen an increase in demand for human therapeutics and vaccines and an even greater need for investment in public health and saf...
A Dedicated Team To Safely Store Your Cell And Virus Banks
The safety of your cell and virus banks must be your top priority. Learn about a team dedicated to the safety of your material along with their related services.
Thermo Fisher Scientific North America Single-Use Technologies Capacity Expansion
Thermo Fisher Scientific is expanding our single-use manufacturing network globally. Some of the largest investments are taking place at our existing Logan, Utah, and Millersburg, Pennsylvania, sites. We are adding space for clean rooms for the manufacturing and assembly ...
How To Improve API Solubility By Salt And Cocrystal Formation
Developing new APIs is complex and costly, especially with poor water solubility (BCS class II and IV). Explore techniques like salt and cocrystal formation to enhance solubility and bioavailability.
Commercial Readiness with Orca Bio's Dan Kirby
Orca Bio's Dan Kirby has played a hand in prepping more than a few approved biologic therapeutic candidates for commercialization. Equally important, he knows firsthand what makes or breaks post-approval commercial efforts, having played virtually every role there is ...
Explore The M Lab Collaboration Center In Burlington MA
Our global network of scientific experts, innovative technologies, and non-GMP facilities, empower drug developers of all sizes to achieve manufacturing excellence and innovation through collaborative exploration and learning. Explore 1 of our 8 global facilities today.
Building LEO Pharma's U.S. Presence with Brian Hilberdink
In many respects, bringing an established foreign biopharma company to the U.S. market is not unlike starting one up from scratch. In other respects, it's even harder. The job's not for the faint of heart, which might be why the Danish company LEO Pharma tapped ve...
Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility
Bionova Scientific shares how a CDMO can offer biopharma companies the flexible capacity they need to meet the growing needs for medicines today and in the future.
ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients
The ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients is the most commonly referenced quality guideline in pharmaceutical product and contains five segments. Watch the video to learn more.
Take A Virtual Tour Of Our Cell Line Development Centre Of Excellence
Explore the advanced capabilities of our Cell Line Development Center in Ulm, Germany. From expert teams to streamlined processes, discover how we support biopharma innovation.
MilliporeSigma Large Scale Capabilities Tour
A detailed look at MilliporeSigma’s new BioReliance® viral vector manufacturing facility and how we have employed the latest innovations and quality systems to deliver best-in-class gene therapy services.
